@article{Mythrey R C_Bheemreddy Myakal_2022, title={Effect of Katibasti, Ksheera Basti & Vatagajankusha Rasa in Gridhrasi Vis A Vis Lumbar Spondylosis - A Case Series}, volume={10}, url={https://ijapr.in/index.php/ijapr/article/view/2365}, DOI={10.47070/ijapr.v10i6.2365}, abstractNote={<p>The symptomatology of <em>Gridhrasi</em> given in Ayurvedic classics are pain in chronological order starting from<em> Sphikpurva, Kati, Prushta, Uru, Janu, Jangha, </em>upto <em>Pada</em>,<em> Sakthna kshepo nighruniyat. </em>The clinical features of lumbar spondylosis can be correlated with <em>Gridhrasi</em> and condition can be treated on the lines of <em>Gridhrasi </em>and<em> Vatavyadhi. </em></p> <p><strong>Objectives:</strong> To evaluate the efficacy of <em>Katibasti</em>, <em>Ksheerabasti</em> and<em> Vatagajankusha rasa</em> as <em>Shamanoushadhi</em> in the management of <em>Gridhrasi</em> vis a vis lumbar spondylosis.</p> <p><strong>Result:</strong> The therapies <em>Katibasti</em>, <em>Ksheerabasti</em> and<em> Vatagajankusha rasa</em> along with the suitable<em> Anupana</em> as<em> Shamanoushadhi</em> chosen for the treatment showed very good results in terms of reducing acute pain as well as radiculopathy.</p> <p><strong>Conclusion:</strong> As the long term or extensive use of NSAID’s, Cox-inhibitors like etoricoxib, muscle relaxants, intervertebral steroid injections and even surgery in the management of lumbar spondylosis will induce serious adverse effect on body, safe and effective therapies like <em>Katibasti</em>, <em>Ksheerabasti</em> and<em> Vatagajankusha rasa </em>along with the suitable<em> Anupana</em> as<em> Shamanoushadhi</em> were selected for treatment. These therapies have not caused any adverse events and improved the condition by arresting the pathogenesis at their respective particular stages. It was observed that the above mentioned Ayurvedic therapies were found to be safe and effective in <em>Gridhrasi</em> vis a vis Lumbar spondylosis.</p&gt;}, number={6}, journal={International Journal of Ayurveda and Pharma Research}, author={Mythrey R C and Bheemreddy Myakal}, year={2022}, month={Jul.}, pages={83-86} }